Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential
Pei‐Suen Tsou, John Varga, Steven O’Reilly
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 10, pp. 596-607
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

The Role of Myofibroblasts in Physiological and Pathological Tissue Repair
Ronen Schuster, Fereshteh S. Younesi, Maya Ezzo, et al.
Cold Spring Harbor Perspectives in Biology (2022) Vol. 15, Iss. 1, pp. a041231-a041231
Open Access | Times Cited: 106
Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
Lin Zhao, Jia‐Mei Chen, Bai Bai, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 17
T cell abnormalities in systemic sclerosis
Wei Jin, Zheng Yan, Ping Zhu
Autoimmunity Reviews (2022) Vol. 21, Iss. 11, pp. 103185-103185
Closed Access | Times Cited: 43
The macrophage polarization in inflammatory dermatosis and its potential drug candidates
Qingru Sun, Shiyu Hu, Zhaohuan Lou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114469-114469
Open Access | Times Cited: 32
Redox Pathogenesis in Rheumatic Diseases
Olivia T. Laniak, Thomas Winans, Akshay Patel, et al.
ACR Open Rheumatology (2024) Vol. 6, Iss. 6, pp. 334-346
Open Access | Times Cited: 9
Senescence and tissue fibrosis: opportunities for therapeutic targeting
Steven O’Reilly, Pei‐Suen Tsou, John Varga
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 8
ALKBH3‐Mediated M1A Demethylation of METTL3 Endows Pathological Fibrosis:Interplay Between M1A and M6A RNA Methylation
Liying Tu, Shuchen Gu, Ruoqing Xu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Role of B-Cell in the Pathogenesis of Systemic Sclerosis
Benjamin Thoreau, Benjamin Chaigne, Luc Mouthon
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
Aurélien Chepy, Louisa Bourel, Vincent Koether, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Epigenetics as a versatile regulator of fibrosis
Yang Liu, Dongsheng Wen, Chiakang Ho, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Back to the future: targeting the extracellular matrix to treat systemic sclerosis
Andrew Leask, Angha Naik, Richard Stratton
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 11, pp. 713-723
Closed Access | Times Cited: 22
Further insight into systemic sclerosis from the vasculopathy perspective
Hao Ren, Licong Liu, Yangfan Xiao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115282-115282
Open Access | Times Cited: 16
Elevated interleukin‐11 in systemic sclerosis and role in disease pathogenesis
Thomas Steadman, Steven O’Reilly
The Journal of Dermatology (2023) Vol. 50, Iss. 10, pp. 1255-1261
Open Access | Times Cited: 14
Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target
Steven O’Reilly
Clinical & Experimental Immunology (2023) Vol. 214, Iss. 2, pp. 154-161
Open Access | Times Cited: 13
Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis
Maya Malaab, Ludivine Renaud, Naoko Takamura, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 2, pp. 268-277
Open Access | Times Cited: 29
The role of endothelin and RAS/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications
Mohsen Rokni, Mina Sadeghi Shaker, Hoda Kavosi, et al.
Arthritis Research & Therapy (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 20
Role of NLRP3 inflammasome in systemic sclerosis
Cong Lin, Zhixing Jiang, Ling Cao, et al.
Arthritis Research & Therapy (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 19
The critical importance of epigenetics in autoimmune-related skin diseases
Lingyu Gao, Qianjin Lu
Frontiers of Medicine (2023) Vol. 17, Iss. 1, pp. 43-57
Closed Access | Times Cited: 11
Metabolic fingerprinting of systemic sclerosis: a systematic review
Victoria González, Daniel Galeano-Sánchez, Jaime Enrique Covaleda-Vargas, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 11
Autoimmune disease: a view of epigenetics and therapeutic targeting
S. Y. Mu, Wanrong Wang, Qiuyu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Epigenetic changes cause aberrantly high expression of SOX11, leading to systemic sclerosis
Yasuhiro Nanri, Satoshi Nunomura, Yuko Honda, et al.
Journal of Investigative Dermatology (2025)
Closed Access
Promoting ER stress in a plasmacytoid dendritic cell line drives fibroblast activation
Beatriz H. Ferreira, Inês S. Silva, Andreia Mendes, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
The complexities of cell death mechanisms: a new perspective in systemic sclerosis therapy
Xue Xia, Chenfei Kong, Xiaoming Zhao, et al.
APOPTOSIS (2025)
Closed Access
An international perspective on the future of systemic sclerosis research
David Abraham, Carol M. Black, Christopher P. Denton, et al.
Nature Reviews Rheumatology (2025)
Closed Access
Systemic pharmacotherapy approaches for the treatment of systemic sclerosis
Stefano Di Donato, Zsuzsanna H. McMahan, Michael Hughes
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Page 1 - Next Page

Scroll to top